Jasper J Rizzo, DO in Cape Coral, FL - Medicare Urology

Jasper J Rizzo, DO is a medicare enrolled "Urology" physician in Cape Coral, Florida. He graduated from medical school in 1986 and has 38 years of diverse experience with area of expertise as Urology. He is a member of the group practice Lee Memorial Health System and his current practice location is 507 Del Prado Blvd S, Cape Coral, Florida. You can reach out to his office (for appointments etc.) via phone at (239) 424-2030.

Jasper J Rizzo is licensed to practice in Florida (license number OS6277) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1992770283.

Contact Information

	Jasper J Rizzo, DO
	507 Del Prado Blvd S, Cape Coral, FL 33990-2618
	(239) 424-2030
	(239) 343-4116

Physician's Profile

Full Name	Jasper J Rizzo
Gender	Male
Speciality	Urology
Experience	38 Years
Location	507 Del Prado Blvd S, Cape Coral, Florida
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Jasper J Rizzo graduated from medical school in 1986

NPI Data:

NPI Number: 1992770283
Provider Enumeration Date: 02/21/2006
Last Update Date: 03/30/2021

Medicare PECOS Information:

PECOS PAC ID: 9931135969
Enrollment ID: I20050712000285

Medical Identifiers

Medical identifiers for Jasper J Rizzo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1992770283	NPI	-	NPPES
207496	Other	FL	AMERIGROUP PROVIDER NUM.
16024	Other	FL	WELLCARE
4234606	Other	FL	AETNA PROVIDER NUMBER
0829612-005	Other	FL	CIGNA PROVIDER NUMBER
37205	Other	FL	OP. ENGIN. PROVIDER #
370916700	Medicaid	FL
739121	Other	FL	FIRST HLTH/CCN PROV. #
258028	Other	FL	AVMED PROVIDER NUMBER
256184	Other	FL	USA MNGD. CR. PROV. #
80602	Other	FL	BCBS PROVIDER NUMBER
OS6277	Other	FL	METCARE PROVIDER NUMBER
P01567037	Other	FL	RR MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	OS6277 (Florida)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Cape Coral Hospital	Cape coral, FL	Hospital
Lee Memorial Hospital	Fort myers, FL	Hospital
Gulf Coast Medical Center Lee Health	Fort myers, FL	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Lee Memorial Health System	8729996608	1022

News Archive

Insomnia drug market will exceed $5.6 billion in 2013

The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Panic disorder is a syndrome characterized by spontaneous and recurrent episodes of incapacitating anxiety. It typically emerges during adolescence or early adulthood and can take an exhausting emotional and physical toll on the body.

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

When blood vessels in the brain rupture, or hemorrhage, and cause a stroke, large areas of the brain can be permanently damaged. Depending on the cause, some brain hemorrhages may hide underlying lesions that can be treated with surgery, embolization, radiation, or other treatments.

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jasper J Rizzo allows following entities to bill medicare on his behalf.

Entity Name	Lee Memorial Health System
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1992873319 PECOS PAC ID: 8729996608 Enrollment ID: O20031118000604

News Archive

Insomnia drug market will exceed $5.6 billion in 2013

The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jasper J Rizzo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jasper J Rizzo, DO Po Box 2147, Fort Myers, FL 33902-2147 Ph: (239) 424-2030	Jasper J Rizzo, DO 507 Del Prado Blvd S, Cape Coral, FL 33990-2618 Ph: (239) 424-2030

News Archive

Insomnia drug market will exceed $5.6 billion in 2013

The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Urology Doctors in Cape Coral, FL

Mark A. Mintz, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 507 Del Prado Boulevard, Cape Coral, FL 33990 Phone: 239-772-0500 Fax: 239-772-3076
James D Borden, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 507 Del Prado Blvd S, Cape Coral, FL 33990 Phone: 239-424-2030 Fax: 239-343-4116
Kelly Johnson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2489 Diplomat Pkwy E, Cape Coral, FL 33909 Phone: 239-652-1800
Dr. Eugene Vladimir Ermolovich, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 507 Del Prado Blvd S, Cape Coral, FL 33990 Phone: 239-424-2030 Fax: 239-343-4116
William P. Evans, MD Urology Medicare: Medicare Enrolled Practice Location: 507 Del Prado Blvd S, Cape Coral, FL 33990 Phone: 239-772-0500 Fax: 239-772-3076
Paul R. Bretton, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 507 Del Prado Blvd S, Cape Coral, FL 33990 Phone: 239-772-0500 Fax: 239-772-3076

Jasper J Rizzo, DO - Medicare Urology in Cape Coral, FL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Insomnia drug market will exceed $5.6 billion in 2013

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Medicare Reassignments

Insomnia drug market will exceed $5.6 billion in 2013

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Insomnia drug market will exceed $5.6 billion in 2013

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Study identifies brain hemorrhage patients most likely to have treatable underlying condition

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

FDA clears Sangamo BioSciences' SB-318 IND application for treatment of MPS I

Urology Doctors in Cape Coral, FL